Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Tianyu Pharmaceutical Co., Ltd.

Why is Zhejiang Tianyu Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 3.32% and Operating profit at -24.33% over the last 5 years

With a growth in Net Profit of 12.78%, the company declared Outstanding results in Sep 25

The company has declared positive results for the last 2 consecutive quarters
NET SALES(HY) At CNY 1,527.66 MM has Grown at 22.92%
ROCE(HY) Highest at 5.29%
INVENTORY TURNOVER RATIO(HY) Highest at 1.04 times

With ROE of 4.15%, it has a fair valuation with a 2.46 Price to Book Value

Over the past year, while the stock has generated a return of 4.20%, its profits have risen by 605.8% ; the PEG ratio of the company is 0.1
At the current price, the company has a high dividend yield of 0.2

Underperformed the market in the last 1 year

The stock has generated a return of 4.20% in the last 1 year, much lower than market (China Shanghai Composite) returns of 15.17%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Zhejiang Tianyu Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Tianyu Pharmaceutical Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Zhejiang Tianyu Pharmaceutical Co., Ltd.

4.48%

0.26

44.77%

China Shanghai Composite

15.17%

1.02

14.86%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.32%

EBIT Growth (5y)

-24.33%

EBIT to Interest (avg)

25.90

Debt to EBITDA (avg)

3.71

Net Debt to Equity (avg)

0.48

Sales to Capital Employed (avg)

0.46

Tax Ratio

11.00%

Dividend Payout Ratio

30.77%

Pledged Shares

Institutional Holding

ROCE (avg)

5.24%

ROE (avg)

4.61%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.46

EV to EBIT

62.26

EV to EBITDA

20.62

EV to Capital Employed

1.97

EV to Sales

3.70

PEG Ratio

0.10

Dividend Yield

0.19%

ROCE (Latest)

3.17%

ROE (Latest)

4.15%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

23What is working for the Company

NET SALES(HY)

At CNY 1,527.66 MM has Grown at 22.92%

ROCE(HY)

Highest at 5.29%

INVENTORY TURNOVER RATIO(HY)

Highest at 1.04 times

RAW MATERIAL COST(Y)

Fallen by -29.72% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at 46.01 %

PRE-TAX PROFIT(Q)

At CNY 75.46 MM has Grown at 76.5%

NET PROFIT(Q)

At CNY 71.48 MM has Grown at 89.39%

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for Zhejiang Tianyu Pharmaceutical Co., Ltd.

Net Sales

At CNY 1,527.66 MM has Grown at 22.92%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Inventory Turnover Ratio

Highest at 1.04 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Pre-Tax Profit

At CNY 75.46 MM has Grown at 76.5%

over average net sales of the previous four periods of CNY 42.75 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 71.48 MM has Grown at 89.39%

over average net sales of the previous four periods of CNY 37.75 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Debt-Equity Ratio

Lowest at 46.01 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -29.72% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales